The highly publicized withdrawal of Redux (dexfenfluramine) and fenfluramine, which were used in combination with phentermine in the fen-phen diet drug (see “Heartache for AHP”), has left the ...

Safety issues that led to the withdrawals of the cannabinoid receptor antagonist Acomplia (rimonabant) and, before that, appetite suppressant Redux (dexfenfluramine), mean that novel products are ...

In April 1996, the US Food and Drug Administration approved dexfenfluramine for extended use as an anorexigen in the United States. At the same time, the use of fenfluramine and phentermine ...

Three years ago the slimming drugs dexfenfluramine and fenfluramine, also known as Adifax and Ponderax, which come from the same chemical family as phentermine were banned. These drugs have been ...

In 1996, the makers of fenfluramine, American Home Products, received approval from the Food and Drug Administration for a slightly different version of the drug, called dexfenfluramine and sold ...

The withdrawal of dexfenfluramine and fenfluramine from the worldwide market in September 1997 also caused a major drop in the use of phentermine, and, fortunately, the exposure of large ...

Researchers anticipate that leptin will have fewer side effects than current controversial weight-loss drugs such as Redux (dexfenfluramine) or fen/phen (fenfluramine and phentermine). Since the ...

Elderly. PPH has been reported when phentermine was combined with fenfluramine or dexfenfluramine and with phentermine alone. Advise patients to report immediately any deterioration in exercise ...